LANZA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 11.141
AS - Asia 5.672
EU - Europa 5.143
SA - Sud America 1.016
AF - Africa 109
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.096
Nazione #
US - Stati Uniti d'America 10.904
SG - Singapore 2.361
IT - Italia 1.700
CN - Cina 1.643
BR - Brasile 858
DE - Germania 785
HK - Hong Kong 552
UA - Ucraina 499
PL - Polonia 479
GB - Regno Unito 383
TR - Turchia 375
FI - Finlandia 300
VN - Vietnam 293
FR - Francia 267
RU - Federazione Russa 192
SE - Svezia 192
CA - Canada 105
MX - Messico 104
IN - India 101
ID - Indonesia 97
NL - Olanda 87
AR - Argentina 72
ES - Italia 52
ZA - Sudafrica 51
JP - Giappone 50
AT - Austria 49
BD - Bangladesh 44
BE - Belgio 42
IQ - Iraq 32
EC - Ecuador 25
LT - Lituania 20
PK - Pakistan 19
CZ - Repubblica Ceca 18
CH - Svizzera 17
MA - Marocco 15
PY - Paraguay 12
RO - Romania 12
CO - Colombia 11
JO - Giordania 11
AU - Australia 10
BG - Bulgaria 10
CL - Cile 10
TN - Tunisia 10
VE - Venezuela 10
IE - Irlanda 9
IR - Iran 9
DZ - Algeria 8
EG - Egitto 8
KR - Corea 8
UY - Uruguay 8
UZ - Uzbekistan 8
IL - Israele 7
KZ - Kazakistan 7
AL - Albania 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
PH - Filippine 6
GR - Grecia 5
PE - Perù 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BO - Bolivia 4
DK - Danimarca 4
HN - Honduras 4
KE - Kenya 4
BH - Bahrain 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
EU - Europa 2
GH - Ghana 2
KH - Cambogia 2
LU - Lussemburgo 2
NI - Nicaragua 2
PT - Portogallo 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TD - Ciad 2
TH - Thailandia 2
TL - Timor Orientale 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
GL - Groenlandia 1
GY - Guiana 1
Totale 23.085
Città #
Singapore 1.330
Ashburn 1.148
Woodbridge 1.011
Fairfield 1.003
Chandler 627
Santa Clara 567
Jacksonville 560
Houston 555
Hong Kong 547
Beijing 538
Ann Arbor 526
Warsaw 464
Seattle 386
Wilmington 339
Cambridge 297
Ferrara 278
Izmir 227
Munich 222
New York 221
Los Angeles 196
Nanjing 192
Dallas 188
Dearborn 164
Princeton 153
Milan 144
Boardman 106
San Diego 103
Rome 96
Helsinki 94
Shanghai 92
Ho Chi Minh City 90
São Paulo 88
Turku 88
Jakarta 78
Bologna 73
Mexico City 67
Nanchang 66
Hefei 64
London 59
Shenyang 58
Chicago 55
Denver 52
Hanoi 49
The Dalles 46
Nuremberg 45
Tianjin 45
Tokyo 43
Buffalo 41
Orem 40
Poplar 39
Stockholm 38
Brooklyn 37
Amsterdam 36
Brussels 36
Montreal 36
Frankfurt am Main 33
Kunming 33
Phoenix 33
Changsha 32
Johannesburg 32
Moscow 32
Redwood City 32
Atlanta 31
Bremen 31
Palermo 31
Boston 30
Jinan 29
Naples 29
Toronto 29
Hebei 28
Jiaxing 27
Manchester 27
Rio de Janeiro 27
Ankara 26
Dong Ket 26
San Francisco 26
Chennai 25
Falkenstein 24
Addison 23
Norwalk 23
Catania 22
Columbus 22
Falls Church 22
San Jose 22
San Mateo 22
Ningbo 20
Orange 20
Belo Horizonte 18
Brasília 18
Da Nang 18
Guangzhou 18
Mountain View 18
Washington 18
Zhengzhou 18
Florence 17
Padova 17
Taizhou 17
Ottawa 16
Vienna 16
Augusta 15
Totale 14.836
Nome #
Adenoma-carcinoma del retto-colon. Linee guida e criteri diagnostici minimi. 1.004
Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs including anti-TNF 373
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 313
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 311
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 268
Perdita di espressione delle proteine MLH1, MSH2, MSH6 ed instabilità dei microsatelliti nel carcinoma dell'endometrio 249
PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development 241
A New Case of Syringocystadenocarcinoma Papilliferum: A Rare Pathology for a Wide-Ranging Comprehension 240
Gastrointestinal stromal tumors and other malignancies: A case series 236
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 234
Histologic and sonographic features of holmium laser in the treatment of chronic venous disease 230
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 220
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2 219
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 217
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 208
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 206
Fhit protein expression in human gastric cancer and related precancerous lesions 200
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 198
An apparently untreatable ulcer of the face 195
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 194
Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability - Response 190
Colorectal tumors: The histology report 189
Loss of cortical GABA terminals in Unverricht–Lundborg disease 189
MicroRNA involvement in hepatocellular carcinoma 188
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 188
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 188
MIR-501 DEPLETION INDUCES CELL CYCLE INHIBITION BY MTOR AND P53 MODULATION IN RENAL CARCINOMA 187
The role of immunohistochemistry in the identification of BRAF V600E mutated colorectal cancer 184
Feasibility of sentinel lymph node (sln) biopsy in colic cancer 182
Amelanotic metastasing melanoma mimicking lung cancer 181
Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients 180
Clinical and technical validation of a genomic classifier (ColoPrint) for predicting outcome of patients with stage II colon cancer. 179
MiR501-5p stimulating the activity of mToR may result a risk factor for a poor prognosis of clear cell kidney carcinoma 175
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 175
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 174
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 173
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 167
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 166
Biologic characterization of hereditary non-polyposis colorectal cancer: Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters 165
Role of MGMT methylation status at time of diagnosis and recurrence for patients with glioblastoma: clinical implications 165
SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer 163
Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. 162
Segmented filamentous bacteria-like organisms in histological slides of ileo-cecal valves in patients with ulcerative colitis 162
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells 161
Genomic classifier coloprint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors 161
Assessment of MLH1 promoter methylation and BRAF gene mutation in colorectal carcinomas with microsatellite instability 160
The prognostic role of gender and MGMT methylation status in glioblastoma patients: The female power 159
Pathologic and molecular features of BRAF mutated colorectal adenocarcinomas 159
Feasibility of sentinel lymph node (sln) byopsy in colic cancer 158
Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization 158
Medullary-type poorly differentiated adenocarcinoma of the large bowel: A distinct clinicopathologic entity characterized by microsatellite instability and improved survival 157
Analysis of BRAF Gene Mutation and MLH1 Promoter Methylation in MSI-H Colorectal Carcinomas with Loss of MLH1 Protein Expression 157
Frequent aberrant methylation of the CDH4 gene-promoter in human colorectal and gastric cancer 157
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 153
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 152
Ependymomas, Malignant Tumors of Pancreatic Islets, and Osteosarcomas Induced in Hamsters by BK Virus, a Human Papovavirus 152
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 151
p53 Expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern, and short-term survival 151
Oncogenic role of miR-483-3p at the IGF2/483 locus 149
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 147
Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection 143
Identification and classification of Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the Study of Hereditary Colorectal Tumors Consensus Group 141
MGMT expression in colorectal cancer: relation to clinicopathologic and molecular features 141
Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood 141
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer 140
Modulation of mismatch repair and genomic stability by miR-155 139
Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal 137
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 136
p53 protein expression in the colorectal adenoma-carcinoma sequence 133
The first two years of colorectal cancer screening in Ferrara, Italy 132
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 131
Sensitive and specific detection of lung cancer DNA in bronchial washing by a novel methylation-specific droplet digital PCR 130
Anti-miR-135b in colon cancer treatment 128
Hsa-microRNA-1249-3p/Homeobox A13 axis modulates the expression of β-catenin gene in human epithelial cells 127
Microsatellite instability in multiple colorectal tumors 126
null 126
Espressione del gene MGMT nel carcinoma colo-rettale: correlazioni cliniche, patologiche e biomolecolari 126
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 125
Targeted Sequencing Approach For Prostate Cancer Using Ion Torrent Personal Genome Machine (PGM ™) Platform 125
A microRNA expression signature of human solid tumors defines cancer gene targets 123
Instabilità dei microsatelliti ed espressione delle proteine del mismatch repair nel carcinoma endometriale 123
Colorectal cancer screening in Ferrara: Results in early (2005-2009) and late (2009-2013) screening periods and surgical treatment of the screenees versus pre-screening (2003-2005) unselected population. 122
PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironment 121
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 121
P3.03-22 IL-1β as a New Early Predictive Biomarker for Non-Small Cell Lung Cancers Outcome 121
Valutazione di parametri prognostici nel carcinoma del colon-retto. II. Ploidia mediante citometria a flusso. 120
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 119
Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of Radiomics 119
Epigenetic Regulation: A Link between Inflammation and Carcinogenesis 119
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 118
Late-onset intrauterine growth restriction and HHV-6 infection: A pilot study 116
Cost-effectiveness of colonoscopy colorectal cancer (CRC) screening in asymptomatic increased risk subjects 114
Prognostic value of flow cytometric DNA ploidy in colorectal cancer 113
null 113
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy 113
Detection of disease-causing mutations in prostate cancer by NGS sequencing 113
Screening patologico per la identificazione dei tumori colo-rettali con deficit del DNA mismatch repair 111
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 111
Methylenetetrahydrofolate reductase 677 C -> T polymorphism and risk of proximal colon cancer in North Italy 111
MICRORNA501 UP-REGULATION MAY INCREASE THE AGGRESSIVENESS OF CLEAR CELL RENAL CARCINOMA THROUGH MTOR ACTIVATION AND P53 DEGRADATION 109
Totale 17.247
Categoria #
all - tutte 106.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.372 0 0 0 0 0 209 93 232 78 313 264 183
2021/20221.558 79 177 109 64 79 75 67 107 57 139 123 482
2022/20231.663 171 111 73 199 217 200 90 157 207 40 113 85
2023/20241.273 101 135 77 44 107 203 84 104 44 55 66 253
2024/20254.416 128 122 327 229 441 427 256 238 718 421 671 438
2025/20265.985 1.089 469 866 1.324 1.597 640 0 0 0 0 0 0
Totale 23.421